These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 30288863)

  • 1. A case report demonstrating potential utility of topical imiquimod for cutaneous Rosai-Dorfman disease.
    Karadag AS; Tekin B; Hurdogan O; Dagdelen D; Dogan O; Buyukbabani N
    Dermatol Ther; 2019 Jan; 32(1):e12759. PubMed ID: 30288863
    [No Abstract]   [Full Text] [Related]  

  • 2. Dome-shaped Papules on the Left Flank: A Quiz. Cutaneous Rosai-Dorfman Disease (sinus histiocytosis with massive lymphadenopathy.
    Roenneberg S; Hegyi I; Kempf W; Kerl K; Guenova E
    Acta Derm Venereol; 2018 Jan; 98(1):165-166. PubMed ID: 28795760
    [No Abstract]   [Full Text] [Related]  

  • 3. Cutaneous Rosai-Dorfman disease successfully treated with low-dose methotrexate.
    Sun NZ; Galvin J; Cooper KD
    JAMA Dermatol; 2014 Jul; 150(7):787-8. PubMed ID: 24789266
    [No Abstract]   [Full Text] [Related]  

  • 4. Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case.
    Frater JL; Maddox JS; Obadiah JM; Hurley MY
    J Cutan Med Surg; 2006; 10(6):281-90. PubMed ID: 17241598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Purely cutaneous Rosai-Dorfman disease].
    Plettenberg H; Artik S; Kuhn A; Megahed M; Ruzicka T; Kruse R
    Hautarzt; 2004 Oct; 55(10):969-71. PubMed ID: 15351867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An unusual case of multiple cutaneous Rosai-Dorfman disease involving two separate parts of the body.
    Jia J; Tian Q; Zhang H; Zheng Y
    Int J Dermatol; 2017 May; 56(5):576-578. PubMed ID: 28255989
    [No Abstract]   [Full Text] [Related]  

  • 7. Cutaneous Rosai-Dorfman Disease Located on the Breast: Rapid Effectiveness of Methotrexate After Failure of Topical Corticosteroids, Acitretin and Thalidomide.
    Nadal M; Kervarrec T; Machet MC; Petrella T; Machet L
    Acta Derm Venereol; 2015 Jul; 95(6):758-9. PubMed ID: 25632986
    [No Abstract]   [Full Text] [Related]  

  • 8. Lenalidomide in the treatment of Rosai Dorfman disease--a first in use report.
    Rubinstein M; Assal A; Scherba M; Elman J; White R; Verma A; Strakhan M; Mohammadi F; Janakiram M
    Am J Hematol; 2016 Feb; 91(2):E1. PubMed ID: 26502013
    [No Abstract]   [Full Text] [Related]  

  • 9. Dapsone as a potential treatment for cutaneous Rosai-Dorfman disease with neutrophilic predominance.
    Chan CC; Chu CY
    Arch Dermatol; 2006 Apr; 142(4):428-30. PubMed ID: 16618860
    [No Abstract]   [Full Text] [Related]  

  • 10. A case of cutaneous Rosai-Dorfman.
    Prada-García MDC; Perandones-González H; Linares-Navarro R
    Int J Dermatol; 2022 Nov; 61(11):e433-e434. PubMed ID: 35073424
    [No Abstract]   [Full Text] [Related]  

  • 11. A case of cutaneous Rosai-Dorfman disease refractory to imatinib therapy.
    Gebhardt C; Averbeck M; Paasch U; Ugurel S; Kurzen H; Stumpp P; Simon JC; Treudler R
    Arch Dermatol; 2009 May; 145(5):571-4. PubMed ID: 19451502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rosai-Dorfman disease treated with methotrexate and low-dose prednisone: case report and review of the literature.
    Nasseri E; Belisle A; Funaro D
    J Cutan Med Surg; 2012; 16(4):281-5. PubMed ID: 22784522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of cutaneous Rosai-Dorfman disease to topical and intralesional steroids.
    Satter EK; Graham BS; Steger JW
    Br J Dermatol; 2003 Sep; 149(3):672-4. PubMed ID: 14511018
    [No Abstract]   [Full Text] [Related]  

  • 14. Cutaneous Rosai-Dorfman disease.
    Merola JF; Pulitzer M; Rosenman K; Brownell I
    Dermatol Online J; 2008 May; 14(5):8. PubMed ID: 18627744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rosai-Dorfman disease: a case report with nodal and cutaneous involvement and review of the literature.
    Kutlubay Z; Bairamov O; Sevim A; Demirkesen C; Mat MC
    Am J Dermatopathol; 2014 Apr; 36(4):353-7. PubMed ID: 23863552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rosai-Dorfman disease masquerading as an isolated cutaneous nodule.
    Sykes AJ; Lamont D; Tallon B; Mortimer NJ
    Australas J Dermatol; 2019 Nov; 60(4):326-327. PubMed ID: 31025314
    [No Abstract]   [Full Text] [Related]  

  • 17. Atypical Primary Cutaneous Rosai Dorfman Disease: A Case Report.
    Kinio AE; Sawchuk MA; Pratt M
    J Cutan Med Surg; 2017; 21(5):460-463. PubMed ID: 28639453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary manifestations revealing Rosai-Dorfman disease.
    Goupil de Bouillé J; de Muret A; Diot E; Dumont P; Plantier L; Diot P; Marchand-Adam S
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Sep; 32(3):275-7. PubMed ID: 26422575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological features of cutaneous Rosai-Dorfman disease and its relationship to IgG4-related disease: a retrospective study.
    Zhang Y; Chen H; Jiang YQ; Xu XL; Zhang W; Zeng XS; Sun JF
    Br J Dermatol; 2019 Oct; 181(4):844-845. PubMed ID: 30920643
    [No Abstract]   [Full Text] [Related]  

  • 20. Successful treatment of disseminated Rosai-Dorfman disease with siltuximab.
    Lee H; King G; Garg K; Pan Z; Tobin J; Robinson WA
    Haematologica; 2018 Jul; 103(7):e325-e328. PubMed ID: 29599203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.